Laser + Bipolar Resection Helpful for Large Prostates Combined treatment deemed safe for benign prostatic hyperplasia; good functional results over 24 months Bipolar transurethral resection of the ...
BPH is the fifth most prevalent non-cancer disorder among men 50 years and older (Rev Urol. 2006;8 [Suppl 3]:S9-S15). Office visits for BPH increased from 10,116 per 100,000 patients in 1994 to 14,473 ...
The treatment of benign prostatic hyperplasia (BPH) that causes lower urinary tract symptoms has advanced enormously since the days when it was a simple choice between no treatment with reassurance, ...
The prospective, double-blind, randomized controlled trial (RCT) enrolled 244 patients to evaluate the Butterfly Prostatic Retraction Device, a minimally invasive, reversible implant that mechanically ...
Our extensive research on the Benign Prostatic Hyperplasia Treatment (2024-2032) offers valuable insights for businesses. This comprehensive report delves into emerging trends, in ...
Profound Medical Corp. (NASDAQ:PROF) is one of the best Canadian stocks with huge upside potential. On June 10, Profound Medical announced the successful completion of the first commercial benign ...
Harnessing Real-World Data and AI to Advance Research and Treatment for Benign Prostatic Hyperplasia
Benign prostatic hyperplasia (BPH) is one of the most common urologic conditions affecting men as they age, with nearly 50% of men over 50 experiencing symptoms. Despite its prevalence, treatment ...
Treatment with the recently approved, minimally invasive Optilume BPH device improves urinary symptoms while preserving sexual function in men with benign prostatic hyperplasia (BPH), concludes a ...
The UK has just seen the first case of treatment for benign prostatic hyperplasia (BPH) with Rezūm™ Water Vapour Therapy using the newly launched Rezūm™ EVO Console at Basingstoke and North Hampshire ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results